
Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update.
Edgewater analyst Joe Wittine expects fourth-quarter revenue growth of 8% to 9% sequentially following fresh channel checks.

Health Catalyst is back in focus after analysts revised fair value from about US$2.10 to roughly US$1.83 per share, which points to a more cautious stance on the stock. Recent research has shifted from earlier optimism with price targets in the US$2 to US$3 range to current levels closer to US$1.80, as analysts weigh execution risks around churn, divestitures and the durability of growth in its health technology offerings. In this article, you will see how these changing targets fit into the...
Key Stats for Pegasystems StockCurrent Price: $37. 63Target Price (Mid): ~$50Street Target: ~$43Potential Total Return: ~33%Annualized IRR: ~7% / yearWhat Happened?Pegasystems (PEGA) did something most beaten-down software companies avoid: it explained, in plain terms, exactly how it lost its own year.

Citigroup (C) closed at $136.18 in the latest trading session, marking a -1.9% move from the prior day.

Bank of America CEO Brian Moynihan said at a conference on Monday that sales and trading revenue for the fiscal third quarter will be flat.
Investing.com -- Citi told clients in a note Tuesday that it expects semiconductor stocks to rebound after a summer slump, arguing that a heavy conference schedule and resilient data center demand should support a sector that had run ahead of expectations.

In a consequential week for Novartis, the Swiss drug maker released results for two of three trials that Wall Street has watched for in the second half of the year.

Citi has reiterated its 'sell' rating on Novo Nordisk (NYSE:NVO), the Danish pharmaceutical group, with a price target of 265 Danish krone against a last close of 292.4 Danish krone. Analyst Emmanuel Papadakis published Citi's weekly IQVIA tracker of Novo's GLP-1 assets, using retail...

Kroger (NYSE:KR) shares fell 1. 2% in pre-market trading after Citi placed the supermarket group on a short-term downside Catalyst Watch ahead of its second-quarter 2026 earnings report.

SEC subpoenas Goldman Sachs, JPMorgan, Citigroup and Bank of America over margin lending to hedge fund Situational Awareness, which suffered a 67% drawdown amid an AI stock sell-off.
The firm sees AI demand setting up a potential rebound.

Citigroup (C) closed at $132.89 in the latest trading session, marking a -3.46% move from the prior day.

Strong earnings reports have helped the S&P 500 reach record levels this quarter. Analysts see more gains ahead, with one saying the index can reach 8100.

China’s credit expansion held up better than expected in July, but weak borrowing demand among households and businesses pushed loans into a worse-than-forecast contraction.
Citi retained its Buy rating but warned that DRAM and NAND pricing momentum could peak during 2027.
Investing.com - Citi slashed its price target on Micron Technology to $1,150 from $1,400 while keeping a Buy rating, citing a more tempered outlook for DRAM and NAND pricing heading into next year.
Citi has downgraded HSBC Holdings PLC (LSE:HSBA, NYSE:HSBC) to 'neutral' from 'buy', arguing that the shares need a breather after one of the strongest runs in the European banking sector this year. The stock is up 40% since January, and the bank now trades on roughly 11 times forward...
Citi has kept its 'neutral' rating on Novo Nordisk (NYSE:NVO), arguing that the market's reaction to a failed heart drug trial looks somewhat overdone while flagging deeper concerns about pricing and competition in obesity. The Danish group announced that ziltevekimab, an anti-inflammatory...
(Bloomberg) -- Leveraged ETFs that offer the tantalizing prospect of doubling or tripling the daily returns of an individual stock are famously risky for investors who buy them. Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSingapore's Gated Island for the Rich Is Marred by Decayed HomesIndia’s Family Offices Embrace Profit-Sharing to Attract Top TalentBessent Joins Japan to Help Reverse Months of Yen LossesSaudi Prince Concerned Over Trump’s Iran Strike Plan: Axios
(Bloomberg) -- Wall Street is racing to roll out complex investment products tied to SpaceX shares that aim to shield buyers from future losses amid a sharp selloff following its market debut.Most Read from BloombergUS Intercepts Iran Attack on Bases, Puncturing Days of CalmSK Hynix Profit Disappoints, Spending Soars to $31 BillionApple Set to Make Big Smart Home Push With Siri AI at CenterNvidia’s $750 Billion in Deals Reignite Circular AI FearsChip Rout Deepens on Circular Funding, China Compe
Citigroup (C) has drawn investor attention after its stock fell 7% following second quarter 2026 earnings, even though the bank reported higher net interest income, net income, and diluted earnings per share compared with a year earlier. See our latest analysis for Citigroup. That post earnings drop sits against a mixed price pattern for Citigroup, with a 1 week share price return of 2.2% and an 11.4% year to date share price return, alongside a 1 month share price decline of 6.8% but a 1...
Are Sandisk investors misreading the latest semiconductor news?
Shares of healthcare services company Agilon Health (NYSE:AGL) fell 10.8% in the afternoon session after Citi downgraded the stock's rating from Neutral to Sell, citing valuation concerns. The downgrade followed a massive 650% rally in 2026, which left the stock trading at a 38% premium compared to its peers. Citi noted this valuation was "too rich," especially since the company faced risks as Medicare Advantage plans sought to retain margins heading into 2027. Despite raising the price target f
KOSPI rebounds 3.6% Tuesday as Citi reaffirms its 10,000 target, calling the selloff a technical correction.
A single report on Chinese memory chip makers sent Micron tumbling and pulled Intel, AMD, and Marvell down with it, raising a question traders need to answer fast: is this a sector-wide buying opportunity or the start of something bigger?
Fiscal AI has polled the consensus earnings estimate at $4.24 per share and revenue of $86.66 billion for Microsoft’s fourth quarter.
Many of the same factors have propelled big banks’ strong performance: a solid economic backdrop with low unemployment, corporate clients’ appetite for executing big deals, and lots of trading activity.
Citigroup stock dove, reversing earlier gains, after the earnings call raised more questions for investors. The bank’s earnings print beat estimates, but during the earnings call Citi maintained its 10% to 11% full-year return on tangible common equity outlook, an important metric for the industry. Citigroup was the worst performing name within the State Street Financial Select Sector ETF, dragging the ETF back to just above the flatline.
Citigroup reported a robust second quarter, with its profits up double-digits. But its stock fell after executives indicated the bank would use the good times to invest in itself. “A stronger environment isn't just upside to report,” Citi CEO Jane Fraser said on a call with Wall Street analysts.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.